MedTrace Logo

Renal Arterial Denervation in Sympathetic Dysautonomia

NCT04314557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2025-07-30

No results posted yet for this study

Summary

The RANSOM registry is considered as a collection of data with the ultimate purpose of gathering information about the effect of renal denervation in patients of the investigator's center and evaluating the results within the usual clinical practice.

The general objective of the study is to evaluate the clinical results (blood pressure, quality of life and levels of catecholamines) as well as safety of renal sympathetic denervation in hypertensive patients, at least in treatment with an antihypertensive drug and with increased variability, considering as such a standard deviation\> 10 mmHg for systolic BP and\> 5 for diastolic BP of its blood pressure levels, measured by ABPM.

Conditions

  • Hypertension
  • Renal Denervation
  • Increased Variability
  • Blood Pressure Disorders
  • Blood Pressure Variability
  • Sympathetic Dysautonomia

Interventions

DEVICE

Renal denervation

Spyral device. Bilateral renal denervation.

Sponsors & Collaborators

  • St Carlos Hospital, Madrid, Spain

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-14
Primary Completion
2025-05-31
Completion
2025-05-31
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04314557 on ClinicalTrials.gov